(Chicago) – Manufacturing Execution Systems professionals within the pharmaceutical, medical device, and diagnostics industries are invited to take part in two days of case studies, discussion sessions, and interactive workshops October 3-4, 2016 at the Pharmaceutical Manufacturing Execution Systems Conference.  The conference, hosted by Q1 Productions, will take place in Charlotte, North Carolina, and will offer opportunities for in-depth question and answer sessions, a variety of case studies, and more.

Since the pharmaceutical industry has been integrating MES solutions within plant-wide operations, some of the most successful MES professionals within the pharmaceutical industry will be on hand to share insights and experiences in MES implementation.  Presenters include Fancisco Mella of Johnson & Johnson, Christian Berg of Genentech, and Dennis Brandl of MESA International.

As the medical device and diagnostics industries begin integrating MES solutions into their framework, this conference will offer perspectives from those who have been there.  Topics to be addressed will include aligning evolving IT with MES, designing EBRs, and standardizing and deploying MES structures across organizations.  This conference will also offer an in-depth analysis and interpretation of the FDA data integrity draft guidance.   

For more information on the Pharmaceutical Manufacturing Execution Systems Conference, please visit http://www.q1productions.com/pharma-mes or email [email protected]. You can also follow the conference on Twitter @Q1Productions, #Q1MES.

About the Organizer

Q1 Productions designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences throughout highly regulated industries in order to provide strategic learning and timely program content. Through a highly structured production process focused on research calls with end-users and key stakeholders in the industry, our team is able to understand the immediate business concerns of today’s leading executives. Whether focusing on new or pending legislative and health policy issues or enhanced technologies or processes that will drive efficiency, our programs provide solutions to the urgent educational and information needs of our attendees.